Is it time to reduce the doxorubicin dosage in in Hodgkin lymphoma therapy?

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-02-26
DOI
https://doi.org/10.3324/haematol.2025.289210
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Is it time to reduce the doxorubicin dosage in in Hodgkin lymphoma therapy?

Eldad J. Dann
Haematologica
Lymphoma Diagnosis and Treatment
article

Is it time to reduce the doxorubicin dosage in in Hodgkin lymphoma therapy?

Eldad J. Dann
article en

Abstract

No abstract available for this paper.
Haematologica
Rambam Health Care Campus (IL)
Zero hunger
Openalex Percentile: Top 43%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.